The regional and cellular localization of the two subtypes of dopamine receptors, DI and D2, have been ascertained in rat forebrain by use of fluorescent dopaminergic antagonist ligands. (R,S)-5-(4'-aminophenyl)-8-chloro-2,3,4,5-tetrahydro-3-methyl-[1lH-3-benzazepin-7-ol, the 4'-amino derivative of the high-affinity Dl-specific antagonist SCH 23390, and the D2 selective antagonist N-(p-aminophenethyl)spiperone were chemically derivatized using the fluorescent compound tetramethylrhodamine. Two distinct populations of dopamine receptors exist in the nervous system (1). The D1 dopamine receptor subtype is positively linked to the activation of the cyclic 3',5'-adenosine monophosphate (cyclic AMP) second messenger system, while the D2 dopamine receptor subtype is linked to a variety of signal transduction mechanisms (2, 3). The pharmacological profiles of these two dopaminergic receptor populations can be discriminated on the basis of their agonist/antagonist specificities (4). The regional distributions of these receptor subtypes have been anatomically distinguished through in vitro autoradiographic localization of radiolabeled antagonist ligands. These previous studies indicate that both receptor subtypes are predominantly located in the basal ganglia and mesolimbic systems (5-7). Cellular localization of the striatal D1 dopamine receptor subtype can be approximated when radioligand binding is combined with the localization of the second messenger, cyclic AMP (8,9). Previous investigations have shown that the cyclic AMPreactive neurons in the caudate nucleus partially project to the substantia nigra (10), and biochemical investigations substantiate that the striatonigral neurons contain a dopamine-sensitive adenylate cyclase activity (11, 12) consistent with the presence of D1 dopamine receptor binding sites. Although the cellular localization of the striatal D2 receptor is unknown, it has been suggested that the cholinergic interneurons of the caudate nucleus have a D2 binding site (13). The recent report ofthe cDNA sequence for the rat brain D2 receptor may help to resolve this issue (14). Another approach taken by some of us (15) has been the specific derivatization of antagonists for the two dopamine receptor classes by using fluorescent moieties. The advantage of application of these derivatized D1-and D2-selective antagonist probes for anatomical determination of the dopamine receptor subtypes is that cellular localization of the binding sites can be distinguished with much higher resolution than by autoradiographic exposure techniques at these magnifications. We report here the regional and cellular localization of the D1 and D2 receptors in fresh-frozen tissue sections of intact rat forebrain using rhodamine-derivatized (R, S)-5-(4'-aminophenyl)-8-chloro-2,3 ,4,5-tetrahydro-3-methyl-[1Hl-3-benzazepin-7-ol (the 4'-amino derivative of SCH 23390) and N-(p-aminophenethyl)spiperone (NAPS) for the D1 and D2 receptors, respectively.
METHODSMale Sprague-Dawley rats (200-250 g) were used to provide experim...